SCHEMBL29940995

SCHEMBL29940995

Brc1ccc(-c2nsc3ccccc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 4/20 0.54
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LSS P48449 11/20 0.41
MAPK1 P28482 1/20 0.40
DCLK1 O15075 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
CHEK2 O96017 1/20 0.38
CSF1R P07333 1/20 0.38
FER P16591 1/20 0.38
CDK2 P24941 1/20 0.38
MARK3 P27448 1/20 0.38
FLT4 P35916 1/20 0.38
FLT3 P36888 1/20 0.38
MAPK9 P45984 1/20 0.38
CSNK1D P48730 1/20 0.38
CLK2 P49760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964514 0.84 KDM4E (0.52) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL11359600 0.81 ALDH1A1 (0.46) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28072438 0.81 KDM4E (0.46) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL30987223 0.80 MAPT (0.60) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28563540 0.80 MAPT (0.60) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL24566449 0.79 MAPT (0.47) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28072437 0.77 KDM4E (0.46) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL11352247 0.77 KDM4E (0.42) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28167685 0.77 EPAS1 (0.57) EPAS1ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL3979992 0.76 LSS (0.48) MAPTLSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed